Latigo is a California-based clinical-stage biotechnology company that researches and develops non-opioid medicines for the treatment of chronic pain.
$150M
Mar 16, 2025
-
Eikon is a California-based biotechnology company that offers solutions such as drug discovery and development for the pharmaceutical sector.
$350.7M
Feb 25, 2025
-
Abcuro is a Massachusetts-based biotechnology company that researches and develops T-cell-based immunotherapies for the treatment of cancer and autoimmune diseases.
$200M
Feb 11, 2025
-
Pleno is a California-based multi-omic instrument platform that offers solutions such as clinical testing and biomedical research for the healthcare industry.
$25M
Dec 11, 2024
-
Frequently Asked Questions about Foresite Capital
What is Foresite Capital investing in?
Foresite Capital has invested in 165 companies including RayThera, Latigo and Eikon
What company did Foresite Capital invest in?
Foresite Capital invested in a total 165 companies including RayThera, Latigo and Eikon
What are the top 5 investments by Foresite Capital?
The top companies in which Foresite Capital invested are RayThera, Latigo, Eikon, Abcuro and Pleno
